These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21527401)

  • 61. Blood group antigens in the intrahepatic biliary tree. II. Type 1 chain N-acetyllactosamine-related carbohydrate antigens in the proliferated bile ductules.
    Jinno K; Moriwaki S; Govindarajan S; Okada Y; Tsuji T
    J Hepatol; 1989 May; 8(3):330-7. PubMed ID: 2732447
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interleukin-5 inhibition of biliary cell chloride currents and bile flow.
    McGill JM; Yen MS; Cummings OW; Alpini G; LeSage G; Pollok KE; Miller B; Engle SK; Stansfield AP
    Am J Physiol Gastrointest Liver Physiol; 2001 Apr; 280(4):G738-45. PubMed ID: 11254501
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cell-kinetic study of proliferating bile ductules in various hepatobiliary diseases.
    Harada K; Kono N; Tsuneyama K; Nakanuma Y
    Liver; 1998 Aug; 18(4):277-84. PubMed ID: 9766825
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Biliary innate immunity and cholangiopathy.
    Harada K; Nakanuma Y
    Hepatol Res; 2007 Oct; 37 Suppl 3():S430-7. PubMed ID: 17931198
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization and response to interleukin 1 and tumor necrosis factor of immortalized murine biliary epithelial cells.
    Paradis K; Le ON; Russo P; St-Cyr M; Fournier H; Bu D
    Gastroenterology; 1995 Oct; 109(4):1308-15. PubMed ID: 7557100
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Biliary atresia: is lack of innate immune response tolerance key to pathogenesis?
    Glaser SS
    Liver Int; 2008 May; 28(5):587-8. PubMed ID: 18433387
    [No Abstract]   [Full Text] [Related]  

  • 67. Toll-like receptor-1 and receptor-2 and Beta-defensin in postcholecystectomy bile duct injury.
    Miranda-Díaz AG; Hermosillo-Sandoval JM; Villanueva-Pérez MA; Román-Pintos LM; García-Iglesias T; Rodríguez-Carrizalez AD; Cardona-Muñoz EG
    Gastroenterol Res Pract; 2015; 2015():216129. PubMed ID: 25755667
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human intrahepatic biliary epithelial cell as a possible modulator of hepatic regeneration: Potential role of biliary epithelial cell for hepatic remodeling in vivo.
    Komori A; Nakamura M; Fujiwara S; Yano K; Fujioka H; Migita K; Yatsuhashi H; Ishibashi H
    Hepatol Res; 2007 Oct; 37 Suppl 3():S438-43. PubMed ID: 17931199
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Reply: To PMID 24481979.
    Tacke F
    Gastroenterology; 2014 Dec; 147(6):1431. PubMed ID: 25457849
    [No Abstract]   [Full Text] [Related]  

  • 70. A new chance to beat diabetic kidney disease: innate immunity and MCP-1: a matter of good and bad macrophages?
    Gnudi L
    Nephrol Dial Transplant; 2015 Apr; 30(4):525-7. PubMed ID: 25801635
    [No Abstract]   [Full Text] [Related]  

  • 71. A new link between innate immunity and hepatic metabolism: attractive unknown place to visit.
    Fukui H
    Hepatobiliary Surg Nutr; 2017 Aug; 6(4):264-267. PubMed ID: 28848750
    [No Abstract]   [Full Text] [Related]  

  • 72. Bile acid-mediated signaling in cholestatic liver diseases.
    Zeng J; Fan J; Zhou H
    Cell Biosci; 2023 Apr; 13(1):77. PubMed ID: 37120573
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bile acids and their receptors: modulators and therapeutic targets in liver inflammation.
    Bertolini A; Fiorotto R; Strazzabosco M
    Semin Immunopathol; 2022 Jul; 44(4):547-564. PubMed ID: 35415765
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies.
    Giordano DM; Pinto C; Maroni L; Benedetti A; Marzioni M
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30275402
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inhibition of notch signaling pathway prevents cholestatic liver fibrosis by decreasing the differentiation of hepatic progenitor cells into cholangiocytes.
    Zhang X; Du G; Xu Y; Li X; Fan W; Chen J; Liu C; Chen G; Liu C; Zern MA; Mu Y; Liu P
    Lab Invest; 2016 Mar; 96(3):350-60. PubMed ID: 26692291
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4.
    Huang YH; Tiao MM; Huang LT; Chuang JH; Kuo KC; Yang YL; Wang FS
    PLoS One; 2015; 10(8):e0136453. PubMed ID: 26305546
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis?
    Kang N; Shah VH; Urrutia R
    Mol Cancer Res; 2015 Apr; 13(4):604-12. PubMed ID: 25548101
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexus.
    Ansari AW; Schmidt RE; Shankar EM; Kamarulzaman A
    J Transl Med; 2014 Dec; 12():341. PubMed ID: 25528160
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Functional role of monocytes and macrophages for the inflammatory response in acute liver injury.
    Zimmermann HW; Trautwein C; Tacke F
    Front Physiol; 2012; 3():56. PubMed ID: 23091461
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Advances in cholangiocyte immunobiology.
    Syal G; Fausther M; Dranoff JA
    Am J Physiol Gastrointest Liver Physiol; 2012 Nov; 303(10):G1077-86. PubMed ID: 22961800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.